Impact BioMedical Inc.
IBO
$0.45
-$0.0225-4.76%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 62.44% | 43.59% | 1.71% | -7.96% | 13.82% |
| Depreciation & Amortization | 0.18% | -0.09% | 0.18% | 0.18% | 0.45% |
| Other Operating Expenses | 150.00% | 46.61% | 847.06% | 1,009.09% | 1,528.57% |
| Total Operating Expenses | -8.96% | -15.62% | -6.58% | -3.16% | 13.39% |
| Operating Income | 8.96% | 15.62% | 6.58% | 3.16% | -15.03% |
| Income Before Tax | -449.07% | -461.27% | 113.08% | 47.27% | 42.10% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -449.79% | -462.02% | 116.86% | 42.95% | 37.14% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -61.46% | -75.40% | -72.61% | -74.47% | -70.91% |
| Net Income | -460.79% | -494.61% | 118.48% | 41.73% | 35.53% |
| EBIT | 8.96% | 15.62% | 6.58% | 3.16% | -15.03% |
| EBITDA | 8.97% | 15.66% | -0.52% | -13.79% | -51.27% |
| EPS Basic | -1,180.85% | -2,506.48% | 259.60% | -135.49% | -73.32% |
| Normalized Basic EPS | 116.56% | 147.13% | 360.06% | -366.25% | -264.11% |
| EPS Diluted | -1,231.54% | -2,451.64% | -81.58% | -137.24% | -89.48% |
| Normalized Diluted EPS | -69.09% | -237.03% | -197.41% | -366.25% | -264.11% |
| Average Basic Shares Outstanding | -75.03% | -82.15% | -78.37% | -57.45% | -35.99% |
| Average Diluted Shares Outstanding | -41.51% | -57.05% | -56.91% | -57.45% | -35.99% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |